Genseq selects Sapio LIMS to power best-in-class NGS services

Sapio’s no-code platform will support genomic sequencing projects carried out in Genseq’s CAP-accredited sequencing laboratory

Genseq, a Dublin-based, CAP-accredited laboratory providing a range of services for biopharma and clinical research, has adopted the science-aware™ lab informatics platform from Sapio Sciences to manage its next-generation sequencing (NGS) and biobanking workflows. Genseq intends to deploy Sapio’s LIMS (Laboratory Information Management System) functionality to automate critical data exchange between instruments and laboratory systems, track sample information from receipt through sequencing, and assess key performance indicators and quality control.

Founded in 2023, Genseq uses state-of-the-art sequencing platforms, including Novaseq, Nextseq, and Nextseq Dx, to ensure excellent quality and accuracy in sequencing data generation. In addition to providing a full range of genomics, transcriptomics, and single-cell sequencing services, Genseq’s biobanking facility can accommodate more than 500,000 samples.

Genseq will use the advanced LIMS functionality from Sapio to track all aspects of sample management, including sample accessioning, storage, quality control, and aliquoting. Genseq will use Sapio’s integrated hCRM (Healthcare Customer Relationship Management) to receive and process orders through their website and improve communication with clients for various laboratory services, including biopharma and clinical research. In addition to assisting Genseq’s scientists in managing the many tasks associated with sequencing, the LIMS will help lab managers gather key metrics about lab processes and assist quality managers in assessing key performance indicators for clients while also providing key data to aid in improving Genseq’s internal processes.

“Because we provide cutting-edge sequencing services, it was important to us to find a modern LIMS that could support our workflows end to end without requiring extensive and time-consuming customization,” said Patrick Buckley, Chief Scientific Officer, at Genseq. “The Sapio platform enables us to carry out consistent, reproducible work and automates key tasks so that our scientists can focus on delivering the best results possible to our clients as quickly as possible.”

The Sapio platform unifies LIMS, electronic laboratory notebook (ELN), and scientific data management functionality in a single cloud system. The company recently announced the inclusion of AI capabilities in its ELN (ELaiN), along with full GxP validation of its platform.

“We’re always proud to support innovative organizations in pushing the boundaries of science and delivering vital services to stoke the next generation of biopharma breakthroughs,” said Kevin Cramer, president and CEO of Sapio Sciences. “Sapio is supporting Genseq in meeting its promise to clients, and we’re excited to partner with them as they grow their capabilities to meet demand.”

Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!

Related posts

Korro Bio Expands Leadership Team with Key Appointments

Business Wire

Almaden Genomics Announces Launch of g.nome™ Platform

PR Newswire

Golden Valley Memorial Healthcare is LIVE with Expanse Genomics

Business Wire